Literature DB >> 26880418

Hypomethylation in Parkinson's disease: An epigenetic drug effect?

Thomas Müller1, Willibald Kohlhepp1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26880418     DOI： 10.1002/mds.26560

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  5 in total

1.  Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy.

Authors:  Carsten Buhmann; R Hilker; P Lingor; C Schrader; J Schwarz; M Wolz; H Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2017-02-22       Impact factor: 3.575

2.  Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson's Disease Patients.

Authors:  Thomas Müller; Eugen Schlegel; Stephanie Zingler; Hans Michael Thiede
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

Review 3.  Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice.

Authors:  Lars Tönges; Carsten Buhmann; Stephan Klebe; Jochen Klucken; Eun Hae Kwon; Thomas Müller; David J Pedrosa; Nils Schröter; Peter Riederer; Paul Lingor
Journal:  J Neural Transm (Vienna)       Date:  2022-04-15       Impact factor: 3.850

4.  Do we need a new levodopa?

Authors:  Thomas Müller
Journal:  Neural Regen Res       Date:  2016-05       Impact factor: 5.135

Review 5.  Lifetime Impact of Cow's Milk on Overactivation of mTORC1: From Fetal to Childhood Overgrowth, Acne, Diabetes, Cancers, and Neurodegeneration.

Authors:  Bodo C Melnik
Journal:  Biomolecules       Date:  2021-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.